Table 2.
Primer set | Sequence (5′–3′) | Amplicon | Accession number | Efficiencies |
---|---|---|---|---|
Pacap | Forward GGAAACCCGCTGCAAGACTTCTAC | 150 bp | M63006 | 1.02 |
Reverse CAAGACTTTGCGGTAGGCTTCGTT | F 136-159 | |||
Probe ACGCCTACGCCCTTTACTACCCAGCCGACA | R 285-262 | |||
P 206-225 | ||||
Glucokinase | Forward CGAGCTTCAAGGAGCGGTTTCAC | 81 bp | NM_012565 | 1.02 |
Reverse CCTCCTCTGATTCGATGAAGGTGATTTCG | F: 1341-1363 | |||
Probe AGTGTGCGCAGGCTGACACCCAACT | R: 1421-1393 | |||
P: 1367-1391 | ||||
Bdnf | Forward AGAAGGTTCGGCCCAACGAAGAAA | 103 bp | NM_012513 | 0.94 |
Reverse AGAAAGAGCAGAGGAGGCTCCAA | F: 890-913 | |||
Probe TCCCGGGTGATGCTCAGCAGTCAAGTGCCT | R: 992-969 | |||
P: 940-968 | ||||
β-actin | Forward AGATGACCCAGATCATGTTTGAGA | 86 bp | NM_031144 | 0.95 |
Reverse ACCAGAGGCATACAGGGACAA | F: 434-457 | |||
Probe TCAACACCCCAGCCATGTACGTAGCC | R: 519-499 | |||
P: 461-486 |
PCR, polymerase chain reaction; VMN, ventromedial nucleus of the hypothalamus; Pacap, pituitary adenylate cyclase–activated polypeptide; Bdnf, brain-derived neurotrophic factor.